» Articles » PMID: 23644718

Invasive Versus Non-invasive Cooling After In- and Out-of-hospital Cardiac Arrest: a Randomized Trial

Overview
Date 2013 May 7
PMID 23644718
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Mild induced hypothermia (MIH) is indicated for comatose survivors of sudden cardiac arrest (SCA) to improve clinical outcome. In this study, we compared the efficacy of two different cooling devices for temperature management in SCA survivors.

Methods: Between April 2008 and August 2009, 80 patients after survived in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) were included in this prospective, randomized, single center study. Hypothermia was induced after randomization by either invasive Coolgard(®) cooling or non-invasive ArcticSun(®) surface cooling at 33.0 °C core body temperature for 24 h followed by active rewarming. The primary endpoint was defined as the efficacy of both cooling systems, measured by neuron-specific enolase (NSE) levels as a surrogate parameter for brain damage. Secondary efficacy endpoints were the clinical and neurological outcome, time to start of cooling and reaching the target temperature, target temperature-maintenance and hypothermia-associated complications.

Results: NSE at 72 h did not differ significantly between the 2 groups with 16.5 ng/ml, interquartile range 11.8-46.5 in surface-cooled patients versus 19.0 ng/ml, interquartile range 11.0-42.0 in invasive-cooled patients, p = 0.99. Neurological and clinical outcome was similar in both groups. Target temperature of 33.0 °C was maintained more stable in the invasive group (33.0 versus 32.7 °C, p < 0.001). Bleeding complications were more frequent with invasive cooling (n = 17 [43.6 %] versus n = 7 [17.9 %]; p = 0.03).

Conclusion: Invasive cooling has advantages with respect to temperature management over surface cooling; however, did not result in different outcome as measured by NSE release in SCA survivors. Bleeding complications were more frequently encountered by invasive cooling.

Citing Articles

A review on targeted temperature management for cardiac arrest and traumatic brain injury.

Ito H, Hosomi S, Nishida T, Nakamura Y, Iba J, Ogura H Front Neurosci. 2024; 18:1397300.

PMID: 39544908 PMC: 11560895. DOI: 10.3389/fnins.2024.1397300.


Temperature control after cardiac arrest.

Elmer J, Callaway C Resuscitation. 2023; 189:109882.

PMID: 37355091 PMC: 10530429. DOI: 10.1016/j.resuscitation.2023.109882.


Heat Transfer Capabilities of Surface Cooling Systems for Inducing Therapeutic Hypothermia.

Leclerc C, Nia M, Giesbrecht G Ther Hypothermia Temp Manag. 2023; 13(3):149-158.

PMID: 37276032 PMC: 10510682. DOI: 10.1089/ther.2023.0003.


Temperature Control After Cardiac Arrest: A Narrative Review.

Fernandez Hernandez S, Barlow B, Pertsovskaya V, Maciel C Adv Ther. 2023; 40(5):2097-2115.

PMID: 36964887 PMC: 10129937. DOI: 10.1007/s12325-023-02494-1.


Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN).

Carnicelli A, Keane R, Brown K, Loriaux D, Kendsersky P, Alviar C Resuscitation. 2022; 183:109664.

PMID: 36521683 PMC: 9899313. DOI: 10.1016/j.resuscitation.2022.12.002.


References
1.
Nielsen N, Sunde K, Hovdenes J, Riker R, Rubertsson S, Stammet P . Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med. 2010; 39(1):57-64. DOI: 10.1097/CCM.0b013e3181fa4301. View

2.
Bernard S, Gray T, Buist M, Jones B, Silvester W, Gutteridge G . Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; 346(8):557-63. DOI: 10.1056/NEJMoa003289. View

3.
Auer J, Berent R, Weber T, Porodko M, Lamm G, Lassnig E . Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. CJEM. 2006; 8(1):13-8. DOI: 10.1017/s1481803500013324. View

4.
Jennett B, Bond M . Assessment of outcome after severe brain damage. Lancet. 1975; 1(7905):480-4. DOI: 10.1016/s0140-6736(75)92830-5. View

5.
Fogel W, Krieger D, Veith M, Adams H, Hund E, Storch-Hagenlocher B . Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med. 1997; 25(7):1133-8. DOI: 10.1097/00003246-199707000-00012. View